Fig. 1: The HR cohort’s overall and event-free survival curves, along with the cumulative incidences of relapse and death. | Leukemia

Fig. 1: The HR cohort’s overall and event-free survival curves, along with the cumulative incidences of relapse and death.

From: Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study

Fig. 1

The number of participants at risk is provided at the bottom of each panel. A Event-free survival and cumulative incidence of death and relapse with 95% confidence intervals. B Overall survival with 95% confidence intervals. C Event-free survival and cumulative incidence of death and relapse by cell lineage. D Event-free survival and cumulative incidence of death and relapse for patients stratified to block therapy on day 15.

Back to article page